Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score–matched cohort analysis

BACKGROUND: Blinatumomab showed a higher complete remission (CR) rate and a safe bridging to allogeneic hematopoietic cell transplantation (allo-HCT) in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (R/R BCP-ALL). OBJECTIVES: We tried to analyze the outcome of blin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jae-Ho, Kwag, Daehun, Lee, Jong-Hyuk, Min, Gi June, Park, Sung-Soo, Park, Silvia, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Kim, Hee-Je, Min, Chang-Ki, Cho, Seok-Goo, Wook Lee, Jong, Lee, Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989437/
https://www.ncbi.nlm.nih.gov/pubmed/36895914
http://dx.doi.org/10.1177/20406207231154713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989437/
https://www.ncbi.nlm.nih.gov/pubmed/36895914
http://dx.doi.org/10.1177/20406207231154713

Ejemplares similares